Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-066171
Filing Date
2025-07-07
Accepted
2025-07-07 17:13:34
Documents
19
Period of Report
2025-08-21

Document Format Files

Seq Description Document Type Size
1 FORM PRE14A tm252555-1_pre14a.htm   iXBRL PRE 14A 1155252
6 GRAPHIC lc_companytsr-4c.jpg GRAPHIC 61600
7 GRAPHIC lc_netloss-4c.jpg GRAPHIC 55146
8 GRAPHIC lg_quoin-4clr.jpg GRAPHIC 12883
  Complete submission text file 0001104659-25-066171.txt   2185571

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20241231.xsd EX-101.SCH 5052
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qnrx-20241231_def.xml EX-101.DEF 2630
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20241231_lab.xml EX-101.LAB 11193
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20241231_pre.xml EX-101.PRE 1781
21 EXTRACTED XBRL INSTANCE DOCUMENT tm252555-1_pre14a_htm.xml XML 116874
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: PRE 14A | Act: 34 | File No.: 001-37846 | Film No.: 251108849
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)